Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CYDY - CytoDyn to discuss DSMC's review of interim analysis in COVID-19 on October 20


CYDY - CytoDyn to discuss DSMC's review of interim analysis in COVID-19 on October 20

CytoDyn (CYDY) will host an investment community webcast on Tuesday, October 20. Management will discuss the recommendations of the Data Safety Monitoring Committee ((DSMC)) following their review of the interim analysis of the first 195 patients enrolled in the Company’s Phase 2b/3 clinical trial for patients with severe-to-critical COVID-19 indications, including a potential regulatory path forward.

For further details see:

CytoDyn to discuss DSMC's review of interim analysis in COVID-19 on October 20
Stock Information

Company Name: CytoDyn Inc
Stock Symbol: CYDY
Market: OTC
Website: cytodyn.com

Menu

CYDY CYDY Quote CYDY Short CYDY News CYDY Articles CYDY Message Board
Get CYDY Alerts

News, Short Squeeze, Breakout and More Instantly...